Allan Kirk serves as Executive at Eledon Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Allan Kirk has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 10, 2026 involved exercising options for 3,430 shares valued at $0.
Allan Kirk currently holds 3,430 shares of Eledon Pharmaceuticals, Inc. (ELDN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Allan Kirk has been a net neutral trader of ELDN stock. They have purchased $0 and sold $0 worth of shares.
Allan Kirk's most recent insider trade was on Jan 10, 2026, when they sold 3,430 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |